These innovative therapies , Retatrutide, represent a remarkable advancement in treating obesity and conceivably related conditions . They all are categorized as GLP-1 hormone activators , meaning these substances to mimic the endogenous GLP-1 hormone , enhancing metabolic secretion and reducing